Diabetes Drugs Avandia and Actos Pose Risk of Heart Failure

RLF Staff

Contributor

0 CommentsPrint ArticleSubscribe

Diabetes patients taking Avandia or Actos are two times as likely to develop heard problems, according to a report published in the August issue of Diabetes Care.

An advisory panel hearing Monday will examine whether Avandia's cardiovascular risks warrant a stronger warning label following a U.S. government review found Avandia's heart risks are far higher than Actos'..

Avandia (rosiglitazone) and Actos (pioglitazone) are from the same family of diabetes drugs and used by more than 3 million diabetic patients across the United States.

For more information on this subject, please refer to our section on Drugs, Medical Devices, and Implants.